Melanin Synthesis Inhibitors
- Name
- Melanin Synthesis Inhibitors
- Accession Number
- DBCAT004163
- Description
Not Available
- Drugs
Drug Drug Description Monobenzone A hydroquinone derivative used to treat vitiligo. Hydroquinone A topical brightening agent used for the treatment of skin disorders associated with hyperpigmentation including melasma, post-inflammatory hyperpigmentation, sunspots, and freckles. Mequinol A topical agent used in combination with tretinoin to treat solar lentigines. - Drugs & Drug Targets
Drug Target Type Monobenzone Tyrosinase target Hydroquinone Tyrosinase target Hydroquinone Serum albumin carrier Hydroquinone Lysosomal alpha-glucosidase enzyme Hydroquinone Cysteinyl leukotriene receptor 1 target